Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation

Dabrafenib and trametinib therapy for BRAF V600E‐mutant non‐small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical practice. However, the efficacy and safety of this combination therapy in elderly patients remain unclear....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorac Cancer
Hauptverfasser: Dotsu, Yosuke, Fukuda, Minoru, Honda, Noritaka, Gyotoku, Hiroshi, Kohno, Yoshihisa, Suyama, Takayuki, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Miyazaki, Taiga, Sakamoto, Noriho, Obase, Yasushi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons Australia, Ltd 2020
Schlagworte:
Case Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812073/
https://ncbi.nlm.nih.gov/pubmed/33215864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13756
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge